Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Pruritus ani |
French
|
Prurit anal |
| Level | Code | Title | |
|---|---|---|---|
| 1 | XII | Diseases of the skin and subcutaneous tissue | |
| 2 | L20-L30 | Dermatitis and eczema | |
| 3 | L29 | Pruritus | |
| 4 | L29.0 | Pruritus ani |
| Active Ingredient | Description | |
|---|---|---|
| Dexchlorpheniramine |
Dexchlorpheniramine, the d-isomer of the racemic compound chlorpheniramine, is two times more active than chlorpheniramine. Dexchlorpheniramine does not prevent the release of histamine, but rather, competes with free histamine for binding at the H1-receptor sites, and competitively antagonizes the effects of histamine on H1-receptors in the GI tract, uterus, large blood vessels, and bronchial muscle. Blockade of H1-receptors also suppresses the formation of oedema, flare, and pruritus that result from histaminic activity. Since dexchlorpheniramine binds to central and peripheral H1-receptors, sedative effects are likely to occur. Dexchlorpheniramine has high antihistaminic activity, moderate anticholinergic effects and minimal sedative effects. |
|
| Hydroxyzine |
Hydroxyzine is a first generation antihistamine, a piperazine derivative, with antimuscarinic and sedative properties. |
|
| Mequitazine |
Mequitazine is a phenothiazine derivative with the actions and uses of antihistamines. Antihistamines diminish or abolish the main actions of histamine in the body by competitive, reversible blaockade of histamine receptor site on tissues; they do not inactivate histamine or prevent its synthesis or release. Antihistamines are used for palliative treatment of allergic reactions. |
